Alexis Demonbreun to Sarcoglycans
This is a "connection" page, showing publications Alexis Demonbreun has written about Sarcoglycans.
Connection Strength
0.825
-
The extracellular matrix differentially directs myoblast motility and differentiation in distinct forms of muscular dystrophy: Dystrophic matrices alter myoblast motility. Matrix Biol. 2024 May; 129:44-58.
Score: 0.237
-
A gene-edited mouse model of limb-girdle muscular dystrophy 2C for testing exon skipping. Dis Model Mech. 2019 11 04; 13(2).
Score: 0.174
-
Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers. JCI Insight. 2018 05 03; 3(9).
Score: 0.157
-
Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping. J Clin Invest. 2015 Nov 02; 125(11):4186-95.
Score: 0.132
-
Nuclear sequestration of delta-sarcoglycan disrupts the nuclear localization of lamin A/C and emerin in cardiomyocytes. Hum Mol Genet. 2007 Feb 15; 16(4):355-63.
Score: 0.071
-
Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy. Am J Pathol. 2017 Nov; 187(11):2520-2535.
Score: 0.037
-
Genetic background influences muscular dystrophy. Neuromuscul Disord. 2005 Oct; 15(9-10):601-9.
Score: 0.016